Vestal Point Capital, LP
Top Portfolio Positions
62 positions ·
$2,372,178,876 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
350,000 | $215,008,500 | 9.06% |
| ACLX |
Arcellx, Inc.
Healthcare
|
2,925,000 | $190,710,000 | 8.04% |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
4,500,000 | $181,800,000 | 7.66% |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
3,000,000 | $178,290,000 | 7.52% |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
4,690,000 | $88,969,300 | 3.75% |
| ALC |
Alcon Inc
Healthcare
|
1,105,000 | $87,085,050 | 3.67% |
| DXCM |
Dexcom Inc
Healthcare
|
1,275,000 | $84,621,750 | 3.57% |
| MRK |
Merck & Co., Inc.
Healthcare
|
775,000 | $81,576,500 | 3.44% |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
13,750,000 | $75,625,000 | 3.19% |
| ABT |
Abbott Laboratories
Healthcare
|
600,000 | $75,174,000 | 3.17% |
Portfolio Trend
Holdings in DBVT
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5,751,000 | 300,000 | Shares | Sole | 2026-02-17 | |
| No quarters match your search. | ||||||